drugset / Trial / NCT05326269

Acute Tocolysis With Terbutaline for Suspected Fetal Distress

NCT05326269

Completed 100 enrolled Hospital Kemaman
RandomizedParallel-groupTriple-blindTreatment

Summary

The trial was to determine the effect of administrating subcutaneous terbutaline prior to emergency caesarean delivery for suspected fetal distress

Timeline

Start
2017-04-23
Primary completion
2019-09-15
Completion
2019-09-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Terbutaline Small molecule 0.25 mg Subcutaneous